ConductScience.org, home

Gene · 246100

CTAG1A: cancer/testis antigen 1A

11 sourcesgene-search-2026-11-11-0.1.0

Download JSON
Cite this record

ConductScience Library. CTAG1A: cancer/testis antigen 1A. Genes, record 246100. Release gene-search-2026-11-11-0.1.0, 11 Nov 2026. https://conductscience.org/library/genes/246100

On this page

Gene

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

Symbol
CTAG1A
HGNC
Name
cancer/testis antigen 1A
HGNC
NCBI Gene ID
246100
NCBI Gene
HGNC ID
HGNC:24198
HGNC
Ensembl
ENSG00000268651
NCBI Gene
Aliases
CT6.1, ESO1, LAGE-2, LAGE2A, NY-ESO-1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P78358Cancer/testis antigen 118023Ensembl, GeneID, HGNC

Source UniProt

Patents391

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
WO 2026209996 A12026-10-08117P78358Espacenet
WO 2026210006 A12026-10-08132P78358Espacenet
JP 2026110597 A2026-07-0213P78358Espacenet
US 12653852 B22026-06-1643P78358Espacenet
JP 2026094307 A2026-06-091P78358Espacenet
JP 2026511570 A2026-04-1422P78358Espacenet
JP 2026509604 A2026-03-1924P78358Espacenet
JP 2026004568 A2026-01-1439899P78358Espacenet
EP 4670728 A12025-12-3122P78358Espacenet
EP 4670732 A12025-12-3124P78358Espacenet

1 to 10 of 391

See all 391 patents

Drugs1

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismAction
RASDEGAFUSP ALFACHEMBL4297923Cancer/testis antigen 1 vaccine antigenVACCINE ANTIGEN

Source ChEMBL

Trials5

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT02661100RASDEGAFUSP ALFAPHASE1/PHASE2ClinicalTrials.gov
NCT02495636RASDEGAFUSP ALFAPHASE2ClinicalTrials.gov
NCT02413827RASDEGAFUSP ALFAPHASE1/PHASE2ClinicalTrials.gov
NCT02129075RASDEGAFUSP ALFAPHASE22021-11-16ClinicalTrials.gov
NCT00948961RASDEGAFUSP ALFAPHASE1/PHASE2ClinicalTrials.gov

NIH grants1,799

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal year
P30CA008748Cancer Center Support Grant852025
P30CA016672Cancer Center Support Grant412025
P30CA016056Roswell Park Cancer Center Support Grant372025
ZIABC010984Adoptive Cell Transfer Immunotherapy of Cancer282025
P30CA016042Cancer Center Support Grant272025
ZIABC010985Gene therapy of cancer242025
R35CA197633Next Generation Cancer Immunotherapies to Defeat Melanoma172025
P30CA044579University of Virginia Cancer Center Support Grant162025
P30CA076292Moffitt Cancer Center Support Grant162025
P30CA047904Cancer Center Support Grant152025

1 to 10 of 1,799Source NIH's project files

See all 1,799 nih grants

Papers4,157

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42775662PubTator, text miningPubMed
42773579PubTator, text miningPubMed
42753002PubTator, text miningPubMed
42738360PubTator, text miningPubMed
42617602PubTator, text miningPubMed
42594762PubTator, text miningPubMed
42517272PubTator, text miningPubMed
42476285PubTator, text miningPubMed
42426163PubTator, text miningPubMed
42419156PubTator, text miningPubMed

1 to 10 of 4,157

See all 4,157 papers

Sources 11

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNone stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GeneNone named. Public domain as US government information
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/246100

GET https://conductscience.org/api/genes/v1/246100/patents?page=2